| Foreword: The Import of Composite Tissue Transplantation | 6 |
|---|
| Preface | 7 |
|---|
| Contents | 8 |
|---|
| Contributors | 12 |
|---|
| Section I | 18 |
|---|
| The Establishment of Composite Tissue Allotransplantion as a Clinical Reality | 19 |
| 1.1 Introduction | 19 |
| The Evolution of Composite Tissue Allotransplantation: the Twentieth Century Realization of “ Cosmas and Damian” | 29 |
| 2.1 Historical Background | 29 |
| 2.2 Current Status | 33 |
| 2.2.1 Trachea | 34 |
| 2.2.2 Peripheral Nerve | 34 |
| 2.2.3 Flexor Tendon Apparatus | 35 |
| 2.2.4 Vascularized Knee | 35 |
| 2.2.5 Lower Extremity | 36 |
| 2.2.6 Larynx | 36 |
| 2.2.7 Abdominal Wall | 36 |
| 2.2.8 Partial Face | 37 |
| 2.2.9 Complete Face/Scalp | 37 |
| References | 38 |
| The Impact of the Discovery of Cyclosporine on Transplantation of Composite Tissue Allografts | 42 |
| 3.1 Introduction | 42 |
| 3.2 History of Composite Transplantation | 42 |
| 3.3 Immunosuppression | 43 |
| 3.4 Cyclosporine: Discovery and Structure | 44 |
| 3.5 Cyclosporine: Mechanism of Action | 46 |
| 3.6 Biologic Effects of Cyclosporine | 46 |
| References | 48 |
| The First Limb Transplants with Cyclosporine | 52 |
| 4.1 Introduction | 52 |
| 4.2 The Questions | 52 |
| 4.3 Materials and Methods | 53 |
| 4.4 Cyclosporine and Limb Transplants | 54 |
| 4.5 The Return of Cosmas and Damian | 54 |
| References | 55 |
| Section II | 56 |
|---|
| Translational Research in Composite Tissue Allotransplantation | 57 |
| 5.1 Introduction | 57 |
| 5.2 Classification of Human Skin Rejection in CTA | 58 |
| 5.3 Development of a Nonhuman Primate Model for the Study of CTA | 60 |
| 5.3.1 Postoperative Management | 62 |
| 5.3.2 Results | 64 |
| 5.4 Conclusions | 65 |
| References | 67 |
| Relative Antigenicity of Allograft Components and Differential Rejection | 69 |
| 6.1 Introduction | 69 |
| 6.2 Components of Vascularized Tissue Allograft | 70 |
| 6.2.1 Skin | 71 |
| 6.2.2 Muscle | 74 |
| 6.2.3 Tendon | 74 |
| 6.2.4 Cartilage | 75 |
| 6.2.5 Bone | 75 |
| 6.2.6 Nerve | 77 |
| 6.2.7 Vessels | 77 |
| 6.3 Discussion | 78 |
| References | 80 |
| On the Road to Tolerance Induction in Composite Tissue Allotransplantation | 84 |
| 7.1 Introduction | 84 |
| 7.2 T-Cell Tolerance | 86 |
| 7.3 Regulatory T Cells | 87 |
| 7.4 T Suppressor Cells | 88 |
| 7.5 Pharmacologic Induction Strategies | 89 |
| 7.6 Costimulation Blockade | 89 |
| 7.7 Donor-Specific Transfusions | 91 |
| 7.8 T-Cell Activation | 91 |
| 7.9 Dendritic Cells | 92 |
| 7.10 Microchimerism | 94 |
| 7.11 Mixed Chimerism | 94 |
| 7.12 Conclusion | 95 |
| References | 96 |
| Donor-Specific Tolerance | 102 |
| 8.1 Introduction | 102 |
| 8.2 Physiologic Mechanisms of Induction Therapy | 103 |
| 8.2.1 T Cells | 103 |
| 8.3 Generation of T Regulatory Cells | 104 |
| 8.4 T-Cell Costimulatory Blockade | 106 |
| 8.5 Donor-Specific Transfusion | 108 |
| 8.6 Gene Therapy for Tolerance Induction | 109 |
| 8.6.1 Gene Therapy Vectors | 110 |
| 8.6.2 Chemokine Antagonists | 111 |
| 8.6.3 MHC Molecules | 112 |
| 8.6.4 Immunosuppressive Cytokines | 112 |
| 8.6.5 Blockage of Costimulatory Signals | 113 |
| 8.7 Conclusion | 114 |
| References | 114 |
| Immune Tolerance Induction: Basic Concepts for Composite Tissue Allotransplantation | 119 |
| 9.1 The Clinical Problem and Possible Solution | 119 |
| 9.2 Immune Tolerance Definition | 120 |
| 9.3 Immune Mechanisms Implicated in Tolerance | 121 |
| 9.3.1 Central Tolerance | 121 |
| 9.3.2 Peripheral Tolerance | 122 |
| 9.4 Composite Tissue Allograft Rejection | 125 |
| 9.5 Strategies for Tolerance Induction in CTA | 126 |
| References | 128 |
| Section III | 132 |
|---|
| Allograft Survival with Calcineurin Inhibitors | 133 |
| 10.1 Introduction | 133 |
| 10.2 Molecular Action of Calcineurin Inhibitors | 133 |
| 10.2.1 Immunosuppression with Calcineurin Inhibitors and Survival of Composite Tissue Allografts in Small Animals | 134 |
| 10.2.2 Immunosuppression with Calcineurin Inhibitors and Survival of Composite Tissue Allografts in Large Animals | 142 |
| 10.2.3 Clinical Applications of Composite Tissue Transplantation and Immunosuppression with Calcineurin Inhibitors | 145 |
| 10.2.4 Short-Term Immunosuppression with Calcineurin Inhibitors and Tolerance Induction in Composite Tissue Allografts | 145 |
| 10.3 Future Solutions | 156 |
| References | 156 |
| Long-Term Prevention of Rejection and Combination Drug Therapy | 162 |
| 11.1 Introduction | 162 |
| 11.2 Combination Drug Therapy | 162 |
| 11.3 First Clinical Applications | 165 |
| 11.4 Hand Transplantation | 167 |
| 11.5 Chronic Rejection | 169 |
| References | 171 |
| Locoregional Immunosuppression in Composite Tissue Allografting | 176 |
| 12.1 Introduction | 176
|